Silence Therapeutics plc Quarterly Operating Income (Loss) in USD from Q1 2024 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Silence Therapeutics plc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2024 to Q2 2025.
  • Silence Therapeutics plc Operating Income (Loss) for the quarter ending June 30, 2025 was -$24M, a 2.46% decline year-over-year.
  • Silence Therapeutics plc annual Operating Income (Loss) for 2024 was -$63.3M, a 1.65% increase from 2023.
  • Silence Therapeutics plc annual Operating Income (Loss) for 2023 was -$64.4M, a 5.48% decline from 2022.
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$24M -$575K -2.46% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$28.4M -$22.8M -409% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q2 2024 -$23.4M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$5.58M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.